Increasing incidence of thyroid cancer has been observed in some countries such as the United States, United Kingdom, France, and so on. Joinpoint regression was used to analyze the incidence of thyroid cancer in Shanghai, China, from 1983 to 2007. The results showed that there were 2 distinct slopes: in men, representing a significant annual percentage change (APC) of 2.6% from 1983 to 2000 (P < .001) followed by a sharp APC of 14.4% (P < .001), and in women, representing a significant APC of 4.9% from 1983 to 2003 (P < .001) followed by a sharp APC of 19.9% (P = .001). The sharp increase in thyroid cancer occurred 5 and 8 years after the iodine supplementation by salt, for men and women, respectively, suggesting that either the developed screening techniques or iodine supplementation might have contributed to the rapid increase in the incidence of thyroid cancer. The burden of thyroid cancer cases is expected to be substantial, based on predictions through 2020.
Introduction
Thyroid cancer is the most common endocrine malignancy and includes a variety of different histological types of neoplasia. The annual incidence of thyroid cancer varies considerably in different registries, with the highest incidence rates in Hawaii, Iceland, and the South Pacific. [1] [2] [3] Compared with other tumors, thyroid cancer is an uncommon cancer, accounting for 1% to 2% of all neoplasms. 4 Over the past few decades, increasing incidence of thyroid cancer has been reported in different countries, including in the United States, 5 the United Kingdom, 6 France, 7 Canada, 8 Australia, 9 Japan, 10 German, 11 Italy, 12 Spain, 13 and some other countries.
In this study, we evaluated the time trends of incidence of thyroid cancer in Shanghai, China, from 1983 to 2007 and then predicted the future burden of thyroid cancer in Shanghai, China, in 2010, 2015, and 2020.
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Methods Participants
Shanghai is situated at 31° 14′ north latitude and 121° 29′ east longitude. It is washed by the East China Sea on the east and Hangzhou Bay on the south and is located at the center along China's coastline. The Shanghai cancer registry was established in 1963. In accordance with the provisions of the Shanghai Bureau of Health, each medical institution, whether inpatient or outpatient, has the responsibility to report new cases of cancer diagnosed. In the study, urban Shanghai covers about 6 million individuals in 9 districts (Huangpu, Luwan, Xuhun, Changning, Jing'an, Putuo, Zhabei, Hongkou, and Yangpu).
Data on incidence and age-standardized rates (Segi's population standard by WHO) of thyroid cancer and total incidence of cancer for each gender were obtained from official publications of the Shanghai Municipal Center for Disease Control and Prevention and Shanghai Cancer Institute 14 and Cancer Incidence in Five Continents. 15 The number of patients suffering from thyroid cancer, the proportion of thyroid cancers among all cancers, and the age-standardized rates of thyroid cancer and total cancer, expressed as rates per 100 000 persons, were used in the trend analysis.
Statistical Methods
Joinpoint regression analysis was carried out to identify points where a statistically significant change over time in linear slope of the trend occurred. 16 In Joinpoint analysis, the best-fitting points where the rate changes significantly (increase or decrease) are chosen. In the final model, each Joinpoint indicates a statistically significant change in trend, and an annual percentage change (APC) is computed for each of those trends by means of generalized linear models, assuming a Poisson distribution. Significant changes include changes in direction or in the rate of increase or decrease.
The future thyroid cancer incidence rates by gender were estimated in urban Shanghai in 2010, 2015, and 2020, using the incidences in 2007 as base and the average APC of the recent slopes or the average APC from 1983 to 2007, respectively.
Results

Incidence of Thyroid Cancer From 1983 to 2007
The results are summarized in Figure 1 . In the year 1983, there were 34 thyroid cancer cases in men and 102 in women in urban Shanghai. This represents 0.4% and 1.7%, respectively, of cases of any cancer ( Figures 1A and 1B ). In the year 2007, however, there were 137 thyroid cancer cases in men and 536 in women ( Figures 1A and 1B) .
In men in Shanghai, thyroid cancer incidence rates adjusted for age tripled between 1983 and 2007, increasing from 1.0 per 100 000 to 3.0 per 100 000 at an APC of 5.0% (95% confidence interval [CI] = 3.9%-6.2%; P < .05; Figure 1C ). On Joinpoint regression, 2 distinct slopes were apparent, representing a significant APC of 2.6% from 1983 to 2000 (P < .001), followed by a sharp APC of 14.4% from 2000 to 2007 (P < .001; Figure 1D ).
Thyroid cancer incidence rates adjusted for age in women more than tripled, from 2.6 per 100 000 to 11.6 per 100 000 at an APC of 6.4% (95% CI = 5.3%-7.4%; P < .05; Figure 1C ). On Joinpoint regression, 2 distinct slopes were apparent, representing a significant APC of 4.9% from 1983 to 2003 (P < .001), followed by a sharp APC of 19.9% from 2003 to 2007 (P = .001; Figure 1E ). 
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Asia-Pacific Journal of Public Health 27 (2) The age-standardized incidence of all cancers in men decreased slightly from 244.4 per 100 000 to 207.9 per 100 000 at an APC of −0.7% (95% CI = −1.0% to −0.4%; P < .001; Figures 1F  and 1G ), whereas that in women increased slightly from 151.6 per 100 000 to 166.4 per 100 000 at an APC of 0.8% (95% CI = 0.6% to ~−1.1%; P <.001; Figures 1F and 1H ).
The Predicted Age-Standardized Incidences of Thyroid Cancer
The predicted age-standardized incidences of thyroid cancer are summarized in Table 1 . If the incidence of thyroid cancer increases at the average APC of the last slope in women (2003 to 2007), it will reach 49.5 per 100 000 in 2015, which would be higher than the rate of incidence of breast cancer in 2007 (31.2 per 100 000, ranked first among all cancers 14 ).
Discussion
Recently, increasing incidence of thyroid cancer has become a global trend. For example, in the United States, the age-adjusted incidence rate (2000 US population) increased from 3.6 per 100 000 in 1973 to 8.7 per 100 000 5 ; in the United Kingdom, the age-standardized incidences (European) have increased from 1.8 to 3.1 per 100 000 population between 1993 and 2007. There has been an especially large increase in female incidence rates, from 2.4 to 4.5 per 100 000 population. 6 Currently, the age-standardized incidence of the total number of cancers in Shanghai only varied slightly, whereas those for thyroid cancer increased from 1.0 to 3.0 per 100 000 population and 2.6 to 11.6 per 100 000 population between 1983 and 2007 in men and women, respectively. As for the increasing trends for thyroid cancer, the condition in Shanghai resembles those in the United States and the United Kingdom.
The reasons for the rise in thyroid cancer incidence are not completely understood, and it remains unclear whether there has been a true increase in the incidence of the cancer or whether this is merely an artifact of improved screening and detection of cancer. Recently, some researchers have suggested that this increase is predominantly a result of improved screening practicesmore widespread use of neck ultrasound and fine-needle aspiration biopsy of small nodules as well as more frequent "incidentalomas" found on nonthyroid ultrasound or cross-sectional imaging. 5, 17 In the present, the increasing trend in urban Shanghai, which is similar to that in the United States and the United Kingdom might suggest that improved screening practices contributed to the increase in incidence of thyroid cancer to some extent. However, because of the absence of the incidence of different histological types, it is impossible to evaluate the extent to which improved screening practices can explain the increasing trend. 
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Morris and Myssiorek 18 performed a detailed population-based analysis of incidence trends in well-differentiated thyroid carcinoma in the Surveillance Epidemiology and End Results (SEER) cancer registry, using weighted least squares and Joinpoint regression models, and concluded that the improved detection did explain increased diagnoses of small thyroid cancers but not that of large cancers (>4 or >6 cm), which still more than doubled between 1973 and 2006. It can be inferred that population-wide dietary, hormonal, or genetic risk factors may play some role in the changing incidence of thyroid cancer. 19 The analysis using Joinpoint regression in our study indicated that there were 2 distinct slopes, a relative slight increase (APC = 2.6%) from 1983 to 2000 and a sharp increase (APC = 14.4%) after 2000 in men and also a relative slight increase (APC = 4.9%) from 1983 to 2003 and a sharp increase (APC = 19.9%) after 2003 in women. This sharp increase happened to occur in 5 and 8 years after 1995, when China fully carried out their state-sponsored program to iodize salts.
Iodine supplementation by means of salt fortification has been proved to be an effective method for the prevention of iodine deficiency disorders. 20 However, the acute increase in iodine intake carries risks, such as development of iodine-induced hyperthyroidism, autoimmune thyroiditis, and hypothyroidism. 21 It has been reported that the incidence of thyroid cancer increased after supplementation of iodine by means of salt. [22] [23] [24] [25] [26] Shanghai is a seaside city and has never had any reported case of Iodine Deficiency Disorder (IDD), suggesting that dietary iodine in Shanghai was sufficient. Thus, the continuous supplementation of iodine may lead to some side effects. In our analysis, the incidences of all cancers decrease or increase a little, whereas the incidence of thyroid cancer increases rapidly, especially after the supplementation of iodine by salt, indicating the existence of risk factors (such as the supplementation of iodine by salt) solely for thyroid cancer but not other types of cancer.
If improved diagnostic practices can fully explain the rising incidence of thyroid cancer, we would expect to find great increases in poorly differentiated thyroid cancers or well-differentiated thyroid cancers of small size (<2 cm), but we would not expect any change in our ability to detect large, well-differentiated thyroid cancers that are already clinically apparent. Thus, iodine supplementation could contribute to the rising incidence of thyroid cancer in part. Because of the absence of details about the incidence of various histological types of thyroid cancer and size distribution, it is impossible to evaluate the extent to which improved screening practices can explain the increasing trend or to exclude the association between supplementation of iodine and the increasing trend.
In addition, the future burden of thyroid cancer in urban Shanghai was predicted using the average APC from 1983 to 2007, when developed screening techniques could explain the increasing incidence of thyroid cancer, or using the average APC of the last slope, when reasons other than developed screening techniques could account for the increasing incidence of thyroid cancer. It should be noted that thyroid cancer is not an extremely rare cancer currently (ranked 13 and 6 in men and women among all types of cancers, respectively, in 2007 14 ) , and neither will it be in the future (see Table 1 ).
The UNICEF program for Universal Salt Iodization (USI) has the benefit of decreasing goiter and the possible risk of increasing thyroid cancer. A surveillance program should be undertaken to investigate thyroid cancer incidence in the coverage area of the USI program, which includes China and 70% of countries in the world. 27 In brief, the study confirms the increasing incidence of thyroid cancer in Shanghai, China, in recent decades and estimates the future burden of thyroid cancer in 2010, 2015, and 2020. Either the developed screening techniques or environmental factors such as iodine supplementation by salt could contribute to this rapid increase in the incidence of thyroid cancer in 5 and 8 years after China fully carried out its state-sponsored program to iodize salts. The burden of thyroid cancer cases is expected to be substantial, based on predictions through 2020.
